Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Cardiology | Internal Medicine | Critical Care | Emergency Medicine | Pathology | Rheumatology | Journal

Back to Journal Articles

Immune-Mediated Diseases May Up Thromboembolism Risk

Last Updated: January 27, 2011.

People admitted to the hospital with immune-mediated diseases may have a higher risk of getting venous thromboembolism, according to research published online Jan. 10 in BMC Medicine.

 

Risk of venous thromboembolism higher in hospitalized patients with these diseases

Share |

Comments: (0)

Tell-a-Friend

 

  Advertisement

THURSDAY, Jan. 27 (HealthDay News) -- People admitted to the hospital with immune-mediated diseases may have a higher risk of getting venous thromboembolism (VTE), according to research published online Jan. 10 in BMC Medicine.

Sreeram V. Ramagopalan, D.Phil., of the University of Oxford in the United Kingdom, and colleagues analyzed databases of linked statistical records of hospital admissions and death certificates for the Oxford Record Linkage Study area from 1968 to 1998 (ORLS1) and 1999 to 2008 (ORLS2) and the whole of England (1999 to 2008). The researchers compared immune-mediated disease cohorts with comparison cohorts to determine rate ratios for VTE.

The researchers found that risk of VTE was significantly higher in all three cohorts in people with a hospital admission record for autoimmune hemolytic anemia, chronic active hepatitis, dermatomyositis/polymyositis, type 1 diabetes mellitus, multiple sclerosis, myasthenia gravis, myxedema, pemphigus/pemphigoid, polyarteritis nodosa, psoriasis, rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus (SLE). Some diseases had higher rate ratios than others did; for example, the rate ratios for SLE were 3.61, 4.60, and 3.71 in ORLS1, ORLS2, and the England cohort, respectively.

"Our data suggest that patients with selected immune-mediated disease may need to be considered for thromboprophylaxis," the authors write.

Abstract
Full Text

Copyright © 2011 HealthDay. All rights reserved.


Previous: Targeting Parents Leads to Sustained Child Weight Loss Next: Transplantation Risk Factors of Delirium Onset Identified

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

 
     

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2016
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.